Biomedical Value Fund, L.P.
Biomedical Value Fund, L.P. is a hedge fund based in Greenwich, Connecticut. According to its most recent Form D, filed Dec 17, 2025, the fund has sold $623,468,953 of interests to 93 investors since its first sale in Sep 2011. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Great Point GP, LLC; Jeffrey Jay; Great Point Partners, LLC.
Performance
No verified returns have been reported for this fund. As a rough guide, Great Point Partners, LLC, which manages it, disclosed U.S. stock holdings that returned an estimated +34.7% 2026 YTD through Jun 30 (S&P 500: +9.5%), based only on its public 13F filings. Over a longer period, Q3 2024 to Q2 2026, the estimate is +58.5% (S&P 500: +37.2%).
This estimate covers the firm's whole disclosed long U.S. stock portfolio. It is not this fund's return and excludes dividends, fees, shorts, derivatives, bonds, cash and trading within each quarter.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $623,468,953Cumulative sales reported on Form D
- Investors
- 93
- First sale
- Sep 30, 2011
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Great Point GP, LLC; Jeffrey Jay; Great Point Partners, LLC
- Latest Form D
- Dec 17, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Biomedical Value Fund, L.P.
What is the minimum investment for Biomedical Value Fund, L.P.?
Biomedical Value Fund, L.P.'s latest Form D, filed Dec 17, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Biomedical Value Fund, L.P.?
Biomedical Value Fund, L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Biomedical Value Fund, L.P. raised?
Biomedical Value Fund, L.P. reports $623,468,953 sold from 93 investors on its Form D filed Dec 17, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Biomedical Value Fund, L.P. based?
Biomedical Value Fund, L.P. is based in Greenwich, Connecticut and is managed by Great Point Partners, LLC.
When did Biomedical Value Fund, L.P. launch?
Biomedical Value Fund, L.P. reports its first sale in Sep 2011.
Size compared with every hedge fund
Raised more than 90% of the 862 hedge funds based in Connecticut, and more than 85% of all 10,307 that report sales.